Literature DB >> 27107777

Freezing effects on the acute myeloid leukemia cell proteome and phosphoproteome revealed using optimal quantitative workflows.

Elise Aasebø1, Olav Mjaavatten2, Marc Vaudel3, Yehia Farag4, Frode Selheim5, Frode Berven6, Øystein Bruserud7, Maria Hernandez-Valladares8.   

Abstract

UNLABELLED: MS-based proteomic studies aiming for the discovery of acute myeloid leukemia (AML) biomarkers require sample processing that can assure an optimal proteome coverage and identification of PTMs. We evaluated different in-solution and filter-aided sample preparation (FASP) proteomic workflows and different enrichment strategies of phosphorylated peptides. The FASP protocols in the label-free and SILAC (stable isotope labelling with amino acids in cell culture) approaches were selected for producing the highest number of quantified proteins with reduced number of missed cleavages. The IMAC method was selected for producing the highest number of quantified phosphopeptides from SILAC-labelled peptides prepared with FASP. Using these selected workflows, we studied the effect of liquid nitrogen storage on the proteome and phosphoproteome of four AML patients. Our results showed that although there was not a major global proteome and phosphoproteome change when compared to their freshly processed counterparts, the freezing appeared to influence the abundance of mitochondrial proteins involved in the respiratory chain transport and affect the phosphorylation of apoptosis related proteins, cell surface interactors, ERK/MAPK targets and proteins involved in thrombin signalling. Our results encourage the assessment of current procedures of AML sample collection and preservation that could be used in future AML biomarker discovery studies. BIOLOGICAL SIGNIFICANCE: Proteomic studies aiming to identify potential cancer biomarkers need to utilize the best sample preparation workflows on the samples of interest to achieve maximal proteome coverage. We have tested the most popular and recent proteomic and phosphoproteomic methods on cell lysates from patients with AML and systematically evaluated their performance. Our study shows the relevance of selecting the patient sample procedure giving the highest protein and PTM coverage. Moreover, we assessed how the proteome and phosphoproteome were affected by the conventional liquid nitrogen storage compared to cell lysis of fresh material, using the methods that worked best in our hands. For potential biomarkers that could be used for AML diagnostic and prognostic, it is of great importance to study the behaviour during sample conservation in order to avoid artefactual findings. Our results recommend caution in data interpretation when using different protocols of sample collection and conservation for proteomic and phosphosproteomic research.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute myeloid leukemia; Biomarkers; Phosphoproteomics; Proteomics

Mesh:

Substances:

Year:  2016        PMID: 27107777     DOI: 10.1016/j.jprot.2016.03.049

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  13 in total

Review 1.  Maximizing Depth of PTM Coverage: Generating Robust MS Datasets for Computational Prediction Modeling.

Authors:  Anthony A Iannetta; Leslie M Hicks
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Reverse phase protein arrays in acute leukemia: investigative and methodological challenges.

Authors:  Fieke W Hoff; Terzah M Horton; Steven M Kornblau
Journal:  Expert Rev Proteomics       Date:  2021-12-29       Impact factor: 4.250

3.  Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report.

Authors:  Era L Pogosova-Agadjanyan; Anna Moseley; Megan Othus; Frederick R Appelbaum; Thomas R Chauncey; I-Ming L Chen; Harry P Erba; John E Godwin; Min Fang; Kenneth J Kopecky; Alan F List; Galina L Pogosov; Jerald P Radich; Cheryl L Willman; Brent L Wood; Soheil Meshinchi; Derek L Stirewalt
Journal:  Biopreserv Biobank       Date:  2017-11-27       Impact factor: 2.256

Review 4.  Selecting Sample Preparation Workflows for Mass Spectrometry-Based Proteomic and Phosphoproteomic Analysis of Patient Samples with Acute Myeloid Leukemia.

Authors:  Maria Hernandez-Valladares; Elise Aasebø; Frode Selheim; Frode S Berven; Øystein Bruserud
Journal:  Proteomes       Date:  2016-08-22

5.  Preservation Method and Phosphate Buffered Saline Washing Affect the Acute Myeloid Leukemia Proteome.

Authors:  Rebecca Wangen; Elise Aasebø; Andrea Trentani; Stein-Ove Døskeland; Øystein Bruserud; Frode Selheim; Maria Hernandez-Valladares
Journal:  Int J Mol Sci       Date:  2018-01-19       Impact factor: 5.923

6.  A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway.

Authors:  Alena Salašová; Chika Yokota; David Potěšil; Zbyněk Zdráhal; Vítězslav Bryja; Ernest Arenas
Journal:  Mol Neurodegener       Date:  2017-07-11       Impact factor: 14.195

7.  Proteomic Profiling of Primary Human Acute Myeloid Leukemia Cells Does Not Reflect Their Constitutive Release of Soluble Mediators.

Authors:  Elise Aasebø; Maria Hernandez-Valladares; Frode Selheim; Frode S Berven; Annette K Brenner; Øystein Bruserud
Journal:  Proteomes       Date:  2018-12-20

8.  Effects of insulin and pathway inhibitors on the PI3K-Akt-mTOR phosphorylation profile in acute myeloid leukemia cells.

Authors:  Ina Nepstad; Kimberley Joanne Hatfield; Ida Sofie Grønningsæter; Elise Aasebø; Maria Hernandez-Valladares; Karen Marie Hagen; Kristin Paulsen Rye; Frode S Berven; Frode Selheim; Håkon Reikvam; Øystein Bruserud
Journal:  Signal Transduct Target Ther       Date:  2019-06-19

9.  Protein expression profiling of plasma and lungs at different stages of metastatic development in a human triple negative breast cancer xenograft model.

Authors:  Maria K Tveitarås; Frode Selheim; Kristina Sortland; Rolf K Reed; Linda Stuhr
Journal:  PLoS One       Date:  2019-05-01       Impact factor: 3.240

10.  Reliable FASP-based procedures for optimal quantitative proteomic and phosphoproteomic analysis on samples from acute myeloid leukemia patients.

Authors:  Maria Hernandez-Valladares; Elise Aasebø; Olav Mjaavatten; Marc Vaudel; Øystein Bruserud; Frode Berven; Frode Selheim
Journal:  Biol Proced Online       Date:  2016-06-21       Impact factor: 3.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.